Amarin Corp Plcuk (AMRN) Equity Average (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Equity Average of $454.3 million for Q1 2026, down 5.33% YoY from $479.9 million in Q1 2025, and down 1.03% sequentially from $459.1 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Equity Average (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Equity Average across 17 years of filings, most recently posting $454.3 million for Q1 2026.

  • In Q1 2026, Equity Average fell 5.33% year-over-year to $454.3 million; the TTM figure through Mar 2026 stood at $454.3 million (down 5.33% YoY), while the FY2025 annual figure was $472.7 million, down 8.94% from the prior year.
  • Equity Average retreated to $454.3 million in Q1 2026, from $459.1 million in the prior quarter.
  • Over the last five years, Equity Average for AMRN reached as high as $654.1 million in Q1 2022 and fell as low as $454.3 million in Q1 2026.
  • The 5-year median for Equity Average is $549.0 million (2024), against an average of $540.8 million.
  • Annual changes were most pronounced in 2022 — Equity Average climbed 3.65% — and 2025, when it slipped 14.72%.
  • A 5-year view of Equity Average shows it stood at $591.6 million in 2022, then retreated by 6.59% to $552.6 million in 2023, then decreased by 7.93% to $508.8 million in 2024, then declined by 9.77% to $459.1 million in 2025, then dropped by 1.03% to $454.3 million in 2026.
  • According to Business Quant data, Equity Average over the past three periods registered $454.3 million, $459.1 million, and $461.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 28.87 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 81.37 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -4.96 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 49.27 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 8.92 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 23.11 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 88.29 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 454.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 454.35 Mn
Dec 31, 2025 459.09 Mn
Sep 30, 2025 461.91 Mn
Jun 30, 2025 469.31 Mn
Mar 31, 2025 479.93 Mn
Dec 31, 2024 508.78 Mn
Sep 30, 2024 541.63 Mn
Jun 30, 2024 548.91 Mn
Mar 31, 2024 549.02 Mn
Dec 31, 2023 552.62 Mn
Sep 30, 2023 561.14 Mn
Jun 30, 2023 576.96 Mn
Mar 31, 2023 590.06 Mn
Dec 31, 2022 591.58 Mn
Sep 30, 2022 583.94 Mn
Jun 30, 2022 610.58 Mn
Mar 31, 2022 654.10 Mn
Dec 31, 2021 654.80 Mn
Sep 30, 2021 643.91 Mn
Jun 30, 2021 639.97 Mn